Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma

Blood

Volumn 92, Issue 9, 1998, Pages 3152-3162

  Kramer, M H H ^b   Hermans, J ^b   Wijburg, E ^b   Philippo, K ^b   Geelen, E ^b   Van Krieken, J H J M ^b   De Jong, D ^b   Maartense, E ^b   Schuuring, E ^b   Kluin, P M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN BCL 6; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; GENE REARRANGEMENT; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; ONCOGENE C MYC; PRIORITY JOURNAL; PROGNOSIS;

EID: 0032211147     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.9.3152     Document Type: Article

References (54)

1. Offit K, Wong G, Filippa DA, Tao Y, Chaganti RSK: Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: Clinical correlations. Blood 77:1508, 1991
2. Yunis JJ, Mayer MG, Arnesen MA, Aeppli DP, Oken MM, Frizzera G: BCL2 and other genomic alterations in the prognosis of large cell lymphoma. N Engl J Med 320:1047, 1989
3. Offit K, Koduru PRK, Hollis R, Filippa D, Jhanwar SC, Clarkson BC, Chaganti RSK: 18q21 rearrangements in diffuse large cell lymphoma: Incidence and clinical significance. Br J Haematol 72:178, 1989
4. Jacobson J, Wilkes B, Kwaiatkowski D, Medeiros J, Aisenberg A, Harris N: BCL2 rearrangements in de novo diffuse large cell lymphoma. Association with distinctive clinical features. Cancer 72:231, 1993
5. Tang SC, Visser L, Hepperle B, Hanson J, Poppema S: Clinical significance of BCL2 mbr gene rearrangement and protein expression in diffuse large-cell non-Hodgkin's lymphoma: An analysis of 83 cases. J Clin Oncol 12:149, 1994
6. Hill ME, MacLennan KA, Cunningham D, Hudson BV, Burke M, Clarke P, Di Stefano F, Anderson L, Hudson GV, Mason D, Selby P, Linch DC: Prognostic significance of BCL2 expression and BCL2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: A British National Lymphoma Investigation study. Blood 88:1046, 1996
7. Gascoyne RD, Adomat SA, Krajewski S, Krajewski M, Horsman DE, Ticher AW, O'Reilly SE, Hoskins P, Coldman AJ, Reed JC, Connors JM: Prognostic significance of BCL2 protein expression and BCL2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. Blood 90:244, 1997
8. Hockenberry D, Nunez G, Miliman C, Schreiber R, Korsmeyer SJ: BCL2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334, 1990
9. Yang E, Korsmeyer SJ: Molecular thanatopsis: A discourse on the BCL2 family and cell death. Blood 88:386, 1996
10. Meijerink J, Mensink E, Wang K, Sedlak T, Slöetjes A, de Witte T, Waksman G, Korsmeyer S: Hematopoietic malignancies demonstrate loss-of-function mutations of BAX. Blood 91:2991, 1998
11. Kerckaert JP, Deweindt C, Tilly H, Quief S, Lecocq G, Bastard C: LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphoma. Nat Genet 5:66, 1993
12. Le Coco F, Ye BH, Lista F, Corradini P, Offit K, Knowles DM, Chaganti RSK, Dalla-Favera R: Rearrangement of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood 83:1757, 1994
13. Bastard C, Deweindt C, Kerckaert JP, Lenormand B, Rossi A, Pezella F, Fruchart C, Duval C, Monconduit M, Tilly H: LAZ3 rearrangements in non-Hodgkin's lymphoma: Correlation with histology, immunophenotype, karyotype and clinical outcome in 217 patients. Blood 83:2423, 1994
14. Offit K, Le Coco F, Louie DC, Parsa NZ, Leung D, Portlock C, Ye BH, Lista F, Filippa DA, Rosenbaum A, Ladanyi M, Jhanwar S, Dalla-Favera R, Chaganti RSK: Rearrangement of the BCL6 gene as a prognostic marker in diffuse large cell lymphoma. N Engl J Med 331:74, 1994
15. Otsuki T, Yano T, Clark HM, Bastard C, Kerckaert JP, Jaffe ES, Raffeld M: Analysis of LAZ3 (BCL6) status in B-cell non-Hodgkin's lymphomas: Results of rearrangement and gene expression studies and a mutational analysis of coding region sequences. Blood 85:2877, 1995
16. Muramatsu M, Akasaka T, Kadowaki N, Ohno H, Yamabe H, Edamura S, Doi S, Mori T, Okuma M, Fukuhara S: Rearrangement of the BCL6 gene in B-cell lymphoid neoplasms: Comparison with lymphomas associated with BCL2 rearrangement. Br J Haematol 93:911, 1996
17. Volpe G, Vitolo U, Carbone A, Pastore C, Bertini M, Botto B, Audislo E, Freilone R, Novero D, Cappia S, De Giuli P, Mazza U, Resegotti L, Palestro G, Saglio G, Gaidano G: Molecular heterogeneity of B-lineage diffuse large cell lymphoma. Genes Chromosomes Cancer 16:21, 1996
18. Ye BH, Chaganti S, Chang C, Niu H, Corradini P, Chaganti R, Dalla-Favera R: Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma. EMBO J 14:6209, 1995
19. Migliazza A, Martinotti S, Chen W, Fusco C, Ye B, Knowles D, Offit K, Chaganti R, Dalla-Favera R: Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphoma. Proc Natl Acad Sci USA 92:12520, 1995
20. Chang C, Ye B, Chaganti R, Dalla-Favera R: BCL-6, a POZ/zincfinger protein, is a sequence specific transcriptional repressor. Proc Natl Acad Sci USA 93:6947, 1996
21. Ye B, Cattoretti G, Shen Q, Zhang J, Hawe N, De Waard R, Leung C, Nouri-Shirazi M, Orazi A, Chaganti R, Rothman P, Stall A, Pandolfi P, Dalla-Favera R: The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet 16:161, 1997
22. Zech L, Haglund U, Nilsson K, Klein G: Characteristic chromosomal abnormalities in biopsies and lymphoid cell lines from patients with Burkitt and non-Burkitt lymphomas. Int J Cancer 17:47, 1976
23. Chenevix-Trench G, Behm FG, Westin EH: Somatic rearrangements of the MYC oncogene in primary human diffuse large-cell lymphoma. Int J Cancer 38:513, 1986
24. Ladanyi M, Offit K, Jhanwar SC, Filippa DA, Chaganti RSK: Myc rearrangements and translocations involving band 8q24 in diffuse large-cell lymphomas. Blood 77:1057, 1991
25. Nagai M, Ikeda K, Tasaka T, Irino S: Genomic rearrangement of the MYC proto-oncogene in non-AlDS-related lymphoma in Japan. Leukemia 5:462, 1991
26. Scarpa A, Borgato L, Chilosi M, Capelli P, Menestrina F, Bonetti F, Zamboni G, Pizzolo G, Hirohashi S, Fiore-Donati L: Evidence of MYC gene abnormalities in mediastinal large B-cell lymphoma of young adult age. Blood 78:780, 1991
27. Cesarman E, Dalla-Favera R, Bentley D, Groudine M: Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma. Science 238:1272, 1987
28. Bradley J, Rothberg P, Ladanyi M, Chaganti R: Hypermutation of the MYC gene in diffuse large cell lymphomas with translocations involving band 8q24. Genes Chromosomes Cancer 7:128, 1993
29. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987, 1993
30. Della D, Borello MG, Berti E, Pierotti MA, Biassoni D, Gianotti R, Alessi E, Rizetti MG, Caputo R, Delia Porta G: Clonal immunoglobulin gene rearrangements and normal T-cell receptor, BCL2, and MYC genes in primary cutaneous B-cell lymphomas. Cancer Res 49:4901, 1989
31. Van Krieken JHJM, Raffeld M, Raghoebier S, Jaffe ES, Van Ommen GJB, Kluin PM: Molecular genetics of gastrointestinal non-Hodgkin's lymphomas: Unusual prevalence and pattern of MYC rearrangements in aggressive lymphomas. Blood 76:797, 1990
32. Van Krieken JHJM, Medeiros J, Pals ST, Raffeld M, Kluin PM: Diffuse aggressive B-cell lymphomas of the gastrointestinal tract: An immunophenotypic and gene rearrangement analysis of 22 cases. Am J Clin Pathol 97:170, 1992
33. Ott G, Katzenberger T, Greiner A, Kalla G, Rosenwald A, Heinrich U, Ott MM, Müller-Hermelink HK: The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res 57:3944, 1997
34. Kramer MHH, Hermans J, Parker J, Krol ADG, Kluin-Nelemans JC, Haak HL, Van Groningen K, Van Krieken JHJM, De Jong D, Kluin PM: Clinical significance of BCL2 and P53 protein expression in diffuse large B-cell lymphoma: A population based study. J Clin Oncol 14:2131, 1996
35. Hermine O, Haioun C, Lepage E, d'Agay MF, Briere J, Lavignac C, Fillet G, Salles G, Marolleau JP, Diebold J, Reyes F, Gaulard P: Prognostic significance of BCL2 protein expression in aggressive non-Hodgkin's lymphoma. Blood 87:265, 1996
36. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M: Report of the Committee on Hodgkin's Disease Staging. Cancer Res 31:1869, 1971
37. Harris ML, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, de Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Müller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A Revised European-American Classification of Lymphoid Neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
38. Lennert K, Feller A: Histopathology of Non-Hodgkin's Lymphomas. New York, NY, Springer, 1992
39. Raghoebier S, Kramer MHH, Van Krieken JHJM, De Jong D, Limpens L, Kluin-Nelemans JC, Van Ommen GJB, Kluin PM: Essential differences in oncogene involvement between primary nodal and extranodal large cell lymphomas. Blood 78:2680, 1991
40. Tsujimoto Y, Gorharn J, Cossman J, Jaffe E, Croce CM: The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229:1390, 1985
41. Dalla-Favera R, Yye BH, Le Coco F, Gaidano G, Lista F, Knowles DM, Louie DC, Offit K, Chaganti RSK: Identification of genetic lesions associated with diffuse large-cell lymphoma. Ann Oncol 5:S55-S60, 1994 (suppl)
42. Tanaka S, Louie D, Kant J, Reed JC: Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin's lymphomas. Blood 79:229, 1992
43. Niedobitek G, Agathanggelou A, Rowe M, Jones EL, Jones DB, Turyaguma P, Oryema J, Wright DH, Young LS: Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma. Blood 86:659, 1995
44. Monni O, Joensuu H, Franssila K, Knuutila S: DNA copy number changes in diffuse large B-cell lymphoma-Comparative genomic hybridisation study. Blood 87:5269, 1996
45. Monni O, Joensuu H, Franssila K, Klefstrom J, Alitalo K, Knuutila S: BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma. Blood 90:1168, 1997
46. Geelen FAMJ, Vermeer MH, Meijer CJLM, van der Putte SCJ, Kerkhof E, Kluin PM, Willemze R: BCL2 protein expression in primary cutaneous large B-cell lymphoma is site-dependent. J Clin Oncol 16:2080, 1998
47. De Jong D, Voetdijk BHM, Beverstock GC, Van Ommen GJB, Willemze R, Kluin PM: Activation of the C-MYC oncogene in a precursor-B-cell blast crisis of follicular lymphoma presenting as a composite lymphoma. N Engl J Med 318:1373, 1988
48. Kramer MHH, Raghoebier S, Beverstock GC, de Jong D, Kluin PM, Kluin-Nelemans JC: De novo acute B-cell leukemia with translocation t(14;18): An entity with a poor prognosis. Leukemia 5:473-478, 1991
49. Bastard C, Tilly H, Lenormand B, Bigogne C, Boulet D, Kunlin A, Monconduit M, Piguet H: Translocations involving band 3q27 and Ig gene regions in non-Hodgkin's lymphoma. Blood 79:2572, 1993
50. Offit K, Louie DC, Parsa NZ, Roy P, Leung D, Le Coco F, Zelenetz A, Dalla-Favera R, Chaganti RSK: BCL6 gene rearrangement and other cytogenetic abnormalities in diffuse large cell lymphoma. Leuk Lymphoma 20:85, 1995
51. Sander CA, Yano T, Clark HM, Harris C, Longo DL, Jaffe ES, Raffeid M: P53 mutation is associated with progression in follicular lymphomas. Blood 82:1994, 1993
52. Le Coco F, Gaidano G, Louie DC, Offit K, Chaganti RSK, Dalla-Favera R: P53 mutations are associated with histologic transformation of follicular lymphoma. Blood 82:2289, 1993
53. Ichikawa A, Hotta T, Takagi N, Tsushita K, Kinoshita T, Nagai H, Murakami Y, Hayashi K, Saito H: Mutations of P53 gene and their relation to disease progression in B-cell lymphoma. Blood 79:2701, 1992
54. Yano T, Jaffe ES, Longo DL, Raffeid M: MYC rearrangements in histologically progressed follicular lymphoma. Blood 80:758, 1992